The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation
Acute lymphoblastic leukemia (ALL) is a malignant disease of the hematologic system. The current treatment is based on chemotherapeutic drugs, which are becoming less effective due to drug resistance. TNF-related apoptosis-inducing ligand (TRAIL) is an apoptotic protein used to treat cancer that doe...
| Автори: | , , , , , , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Compuscript Ltd
2024-04-01
|
| Серія: | Acta Materia Medica |
| Онлайн доступ: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0008 |